Search for:

The word or phrase you're searching for
Within sections:






The sections you wish to include in your search

Search Results

 
Displaying 11 - 20 of 31 results.
Legislation
and Control of Supply of Cannabis for Medical Use) Regulations 2019 (SI 262/2019) Misuse of Drugs, 282/2019) Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations 2019 (SI 583/2019) Misuse of Drugs (Prescription and Control of Supply of Cannabis, 2020 (SI 99/2020) Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use, (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations 2021 (SI 557/2021
Authority Report for the meeting of 24 January 2018
with the matter. 11 Cannabis for Medical Use Regulation Bill 2016 A paper outlining developments in cannabis for medical use was presented. This covered the political background, including the above Bill, the HPRA review and the proposed cannabis access programme. A thematic discussion, role in relation to a Cannabis Authority once the legislation has been passed. From the analysis
Authority Report for meeting of 1 December 2016
assist with training and development. - With regard to the medicinal use of cannabis, the Chief, to the review of cannabis derived medicines, it was noted that at the request of the Minister for Health the HPRA has agreed to provide an expert opinion on medicinal cannabis. To Authority Meeting Report
Report of the Meeting 15 November 2021
” and make various other minor changes.  Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations 2021 (SI 557/2021): An update to list certain cannabis products or preparations for medical use as being eligible for under the cannabis access programme
Authority Report for meeting of 27 January 2016
use of cannabis. - The medical devices legislation recast is progressing as is the matter
Authority Report for Meeting of 10 May 2017
in relation to the development of an implementation programme for cannabis facilitated
Authority Report for Meeting of 20 September 2017
of cannabis for medical use. The HPRA’s role is now limited to technical representation on the Expert
Authority Report for the meeting of 6 December 2018
established medicines network. An update on medical cannabis was provided. The Department of Health
Authority Report for the meeting of 2 May 2019
implants and BIA-ALCL; valproate; cannabis; and the Children and Family Act as it relates to assisted
Authority Report for the meeting of 23 June 2022
of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations